Position
Secretary
Company
OnKure Therapeutics
BoulderBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharmaDescription
OnKure, Inc announced the appointment of Rogan Nunn as General Counsel and Secretary. Mr Nunn will be a member of OnKure’s Executive Team, reporting to Nicholas Saccomano, President and Chief Executive Officer, and will oversee all aspects of the Company’s legal and compliance functions.
Quick answer
OnKure, Inc. Appoints Rogan Nunn as General Counsel and Secretary (June 19, 2024). OnKure Therapeutics is based in Boulder, Colorado, United States.
- Who is the new Secretary at OnKure Therapeutics?
- OnKure Therapeutics named Rogan Nunn Secretary, announced June 19, 2024.
- What did OnKure Therapeutics announce on June 19, 2024?
- OnKure, Inc announced the appointment of Rogan Nunn as General Counsel and Secretary. Mr Nunn will be a member of OnKure’s Executive Team, reporting to Nicholas Saccomano, President and Chief Executive Officer, and will oversee all aspects of the Company’s legal and compliance functions.
- What does OnKure Therapeutics do?
- OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated...
- Where is OnKure Therapeutics based?
- OnKure Therapeutics is based in Boulder, Colorado, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (June 20, 2024), MBX Biosciences, Inc. (June 25, 2024), Crinetics Pharmaceuticals (May 30, 2024) and Terns Pharmaceuticals (May 8, 2024) also announced leadership changes within 45 days of OnKure Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Appoints Roxanne S. Austin as Lead Independent Director (June 20, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Terns Pharmaceuticals Appoints Scott Harris as Chief Development Officer and Announces Departure of Erin Quirk, M.D., President, Head of Research and Development (May 8, 2024)
- Seaport Therapeutics Appoints Antony Loebel, M.D. as Chief Medical Officer and President of Clinical Development, and Lana Gladstein, J.D. as General Counsel (June 18, 2024)
- Novita Pharmaceuticals Appoints Dr. Jose Jimeno as Chief Medical Officer (June 11, 2024)
Who to call at OnKure Therapeutics, and when
A new leader at OnKure Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day OnKure Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OnKure Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OnKure Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OnKure Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OnKure Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.